
    
      The purpose of this study is to evaluate level of test medication with respect to time in the
      body, and safety when compared with the reference medication Subject will be randomly
      assigned to receive an intravenous infusion of either SPARC1613 delivered over 25 (±1)
      minutes or Reference1613 delivered over 30 (±1) minutes
    
  